Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Auton Neurosci. 2014 Oct 23;188:19–23. doi: 10.1016/j.autneu.2014.10.018

AUTONOMIC RESPONSES TO EXERCISE: GROUP III/IV MUSCLE AFFERENTS AND FATIGUE

Markus Amann 1,2, Simranjit K Sidhu 1, Joshua Weavil 2, Tyler Mangum 2, Massimo Venturelli 3
PMCID: PMC4336599  NIHMSID: NIHMS642401  PMID: 25458423

Abstract

Group III and IV muscle afferents originating in exercising limb muscle play a significant role in the development of fatigue during exercise in humans. Feedback from these sensory neurons to the central nervous system (CNS) reflexively increases ventilation and central (cardiac output) and peripheral (limb blood flow) hemodynamic responses during exercise and thereby assures adequate muscle blood flow and O2 delivery. This response depicts a key factor in minimizing the rate of development of peripheral fatigue and in optimizing aerobic exercise capacity. On the other hand, the central projection of group III/IV muscle afferents impairs performance and limits the exercising human via its diminishing effect on the output from spinal motoneurons which decreases voluntary muscle activation (i.e. facilitates central fatigue). Accumulating evidence from recent animal studies suggests the existence of two subtypes of group III/IV muscle afferents. While one subtype only responds to physiological and innocuous levels of endogenous intramuscular metabolites (lactate, ATP, protons) associated with ‘normal’, predominantly aerobic exercise, the other subtype only responds to higher and concurrently noxious levels of metabolites present in muscle during ischaemic contractions or following, for example, hypertonic saline infusions. This review discusses the mechanisms through which group III/IV muscle afferent feedback mediates both central and peripheral fatigue in exercising humans. We also briefly summarize accumulating evidence from recent animal and human studies documenting the existence of two subtypes of group III/IV muscle afferents and the relevance of this discovery for the interpretation of previous work and the design of future studies.

Keywords: Neural feedback, central fatigue, exercise pressor reflex, circulation, ventilation


Both whole body (e.g. cycling) and single joint (e.g. isometric / dynamic knee extension) exercise of sufficient duration and intensity reduces the force / power generating capacity of muscles involved in the task. This exercise-induced decrease is determined by a peripheral and a central [i.e. related to the central nervous system (CNS)] component (3, 26). ‘Peripheral fatigue’ encompasses biochemical changes within the contracting muscle leading to an attenuated force / power response to neural excitation. ‘Central fatigue’, structurally including the brain and the spinal cord, refers to the decrease in force / power secondary to a reduction in descending motor drive and the efficacy of the afferent pathways which combined result in a decrease in the output from spinal motoneurons and thus voluntary muscle activation. Both components of fatigue have previously been linked to group III and IV muscle afferent feedback.

In order to assure a sufficient link to the original work in the face of a restricted number of references, we would be citing various other review articles.

Group III/IV Muscle Afferent Feedback and Exercise: Some Basics

With the onset of exercise, contraction-induced mechanical and chemical stimuli begin to activate molecular receptors located on the terminal end of both thinly myelinated (group III) and unmyelinated (group IV) nerve fibers with their receptive fields within skeletal muscle. The exercise-induced activation of these receptors increases the spontaneous discharge of the thin fiber muscle afferents (1, 37, 40) (Figure 1) that project via the dorsal horn of the spinal cord (62, 63) to various spinal and supraspinal sites within the CNS (18, 20, 21). Although the role of group III/IV muscle afferents in the circulatory regulation during exercise has been recognized nearly 80 years ago [(2), for review see (51)], their fundamental importance in determining exercise hyperpnea was not unanimously agreed upon until recently [for review see (22)], and their contribution to the development of central fatigue has only been investigated in the last 40 years (16).

Figure 1.

Figure 1

Discharge frequency [impulses per 2 seconds; (Imp/2 s)] of group III (panel A) and group IV (panel B) muscle afferents recorded from dorsal root before, during, and after locomotor exercise evoked by electrical stimulation of the mesencephalic locomotor region in decerebrate cats. The horizontal bar denotes the exercise period. Note the immediate increase of both group III and IV locomotor muscle afferent discharge at the onset of exercise and the maintained response until the exercise is terminated. From Adreani et al. (1).

With the exception of a few experimental approaches to reduce sensory feedback during and after exercise in humans [e.g. (28)], the majority of investigations have ‘artificially’ increased neural discharge of group III/IV muscle afferents to study their role in cardiovascular muscle reflex mechanisms and central fatigue. This approach has included, but was not limited to, intramuscular hypertonic saline (or other metabolite) infusions to stimulate nociceptive muscle afferents (e.g. (42) and post exercise circulatory occlusion (PECO) techniques (e.g. (23)) to trap metabolites within a muscle via a blood pressure cuff to maintain/raise neural feedback for as long as the muscle is held ischaemic.

Group III/IV Muscle Afferent Feedback Effects on the Development of Peripheral Fatigue

The role of group III/IV muscle afferents on the development of peripheral fatigue is manifested through their contribution to the cardiovascular, hemodynamic, and ventilatory adjustments occurring during exercise. Increases in these parameters arising with the onset of exercise are, next to central command (60), largely determined by neural feedback from the working muscle and assure augmented blood flow and O2 delivery to the working muscle (13, 19, 33, 35, 43, 59). Both of these variables depict key components in the rate of development of peripheral fatigue during exercise (15, 24, 36). Specifically, decreases in blood flow/O2 delivery exacerbate this rate, whereas increases in blood flow/O2 delivery attenuate this rate [for review see (6)].

In a recent study designed to investigate the role of group III/IV locomotor muscle afferents in the development of peripheral locomotor muscle fatigue, intrathecal fentanyl was used to attenuate sensory feedback from the lower limb during constant-load leg cycling (5). Peripheral fatigue was quantified via the pre- to post-exercise decrease in quadriceps twitch force evoked via supramaximal femoral nerve stimulation. Earlier studies utilizing an identical pharmacological approach to temporarily block group III/IV muscle afferents have documented that exercise in the absence of sensory feedback is characterized by substantial hypoventilation and an attenuated exercise pressor response including decreased central (i.e. cardiac output) and peripheral (leg blood flow) hemodynamic responses during exercise (4, 5, 7-9, 25). Consequently, when constant-load leg cycling is performed in the absence of locomotor muscle afferent feedback, leg blood flow and O2 delivery are markedly attenuated compared to the same exercise performed with an intact neural feedback mechanism. Given the critical role of blood flow/O2 delivery in the development of fatigue [see above; (6)], the rate of accumulation of peripheral fatigue is up to 60% faster during exercise with impaired vs intact group III/IV muscle afferent feedback (5, 54, 55). Taken together, by facilitating circulatory and ventilatory responses, group III/IV muscle afferent feedback ensures adequate muscle blood flow/O2 delivery during exercise and thereby prevents premature fatigue at the level of the locomotor muscle. This neural feedback mechanism plays an important role in optimizing fatigue resistance during physical activities in healthy humans.

The arterial baroreflex has been suggested to attenuate the central effects of group III/IV muscle afferents on the exercise pressor response via their interaction in the nucleus tractus solitarii (38, 52, 61). In other words, group III/IV-mediated pressor responses to exercise have been documented to be larger in the absence of the arterial baroreflex. Based on previous experiments in endurance exercising humans showing that attenuated feedback from group III/IV locomotor muscle afferents causes a reduced muscle blood flow/O2 delivery and accelerated rate of peripheral fatigue (4, 5, 9), it could be speculated that arterial baroreflex buffering of group III/IV-mediated muscle reflexes exacerbates the development of peripheral fatigue during exercise. However, Waldrop and Mitchell have shown that the arterial baroreflex modulates the pressor response without changing muscle blood flow during induced muscular contraction in anesthetized cats (61). Although unknown in humans, if baroreceptor buffering of muscle afferents does not restrict blood flow to the working muscle, it could be argued that it does not affect the development of peripheral fatigue.

It is important to note that the role of group III/IV muscle afferents in the development of peripheral fatigue might be different in patients with heart failure (12) which are characterized by muscle reflex abnormalities (29, 49) with exaggerated afferent feedback as the likely underlying mechanism (44, 46, 48). Although feedback from these neurons still facilitates central hemodynamics in this population (12), it has been documented to account for the excessive hyperventilatory response (47) and exaggerated sympathoexcitation (12, 46) during physical activity in these patients. Recent data demonstrates that when heart failure patients perform single-leg knee-extensor exercise with pharmacologically (lumbar intrathecal fentanyl) blocked group III/IV muscle afferents, sympathetic outflow is attenuated and leg blood flow/O2 delivery significantly increased compared to control exercise. Importantly, this increase secondary to reduced input from group III/IV muscle afferents causes an attenuated rate of fatigue development in these patients (12) (Figure 2). Therefore, in contrast to healthy individuals in which group III/IV muscle afferent feedback attenuates the rate of peripheral fatigue during exercise (5, 54, 55), the abnormally elevated neural feedback associated with chronic heart failure exacerbates the rate of development of fatigue in these patients (12). To our knowledge, there is currently no data available on the effects of other diseases characterized by abnormal neural feedback from group III/IV muscle afferents (e.g., hypertension) on the development of central and peripheral fatigue during exercise.

Figure 2.

Figure 2

Reduction in quadriceps maximal voluntary contraction strength (MVC) induced via 9 minutes of constant-load single leg knee-extensor exercise (25/50/80% of peak workload, 3 min each) in patients with chronic heart failure. The exercise was performed with intact (Control) and blocked (Fentanyl) neural feedback from the lower limb. From Amann et al. (12).

Group III/IV Muscle Afferent Feedback Effects on the Development of Central Fatigue

The involvement of group III/IV muscle afferents in the development of central fatigue during exercise is mediated through their inhibitory effect on the output from spinal motoneurons (i.e. neural ‘drive’ to motor units) which causes a reduction in muscle activation and consequently exercise performance (7, 8, 11, 16, 27, 54-56). This was initially shown during maximal isometric exercise of a single muscle / muscle group [for a review see (26)]. For example, when the discharge rate, and thus the central projection, of group III/IV muscle afferents is maintained following a 2 min maximal voluntary elbow flexor contraction (via PECO), spinal motoneuronal output and voluntary muscle activation remain low and do not recover until circulation is restored and the firing frequency of group III/IV muscle afferents recovers (27, 57).

The inhibitory effect of group III/IV muscle afferents on the output from spinal motoneurons and the associated decrease in exercise performance (secondary to reduced muscle activation) is also of critical relevance during whole-body exercise. Specifically, when subjects perform high-intensity cycling exercise with pharmacologically blocked group III/IV locomotor muscle afferents, the inhibitory effect of these sensory neurons is ‘attenuated’ and the output from spinal motoneurons less restricted and significantly higher compared to that observed during the identical exercise performed with intact feedback (5, 7, 8). More recent cycling studies used lumbar intrathecal fentanyl to block group III/IV locomotor muscle afferents during strenuous cycling exercise to investigate their role on maximal voluntary muscle activation (key indicator of central fatigue) after exercise. While maximal voluntary quadriceps activation was substantially decreased immediately after exhaustive bike exercise with intact feedback, this impact was abolished when the same exercise was repeated with blocked locomotor muscle afferents (54). Furthermore, it is interesting that group III/IV-mediated locomotor muscle feedback associated with exhaustive leg cycling also compromise maximal voluntary muscle activation (during and after exercise) of a remote muscle group (i.e. elbow flexors) not directly involved in the task (55). These recent findings directly emphasize the significant involvement of group III/IV muscle afferents in the development of central fatigue during intense whole body endurance exercise.

Investigating the effect of group III/IV muscle afferents on whole body exercise performance is challenging. The difficulty has been arising from the twofold role these neurons play in an exercising human. Specifically, although they limit spinal motoneuronal output and facilitate central fatigue (i.e. limiting effect on performance), their contribution to the prevention of premature peripheral fatigue by facilitating circulatory and ventilatory responses during exercise is essential (i.e. facilitating effect on performance; see above). Therefore, manipulating muscle afferents during exercise affects both sides and the net effect depends on how one effect outweighs the other. In a recent study designed to circumvent this caveat, subjects were asked to perform dynamic single leg knee-extensor exercise to exhaustion in one leg immediately followed by the identical task in the other leg (11). The goal was to determine whether afferent feedback arising from the knee-extensor exercised/exhausted first inhibits spinal motoneuronal output and thereby limits endurance exercise performance of the consecutively exercising contralateral knee-extensor. The design of the study and additional control experiments allowed the exclusion of other limiting and confounding influences on the endurance performance of the consecutively exercising contralateral knee-extensor (e.g. lack of peripheral fatigue, uncompromised ventilatory and/or hemodynamic responses, etc.). Afferent feedback associated with exercise to exhaustion in the first leg (~9 min) reduced endurance time to exhaustion of the consecutively exercised contralateral leg by ~49% (from ~9 min to ~5 min). It was concluded that group III/IV muscle afferent feedback associated with exhaustive endurance exercise has an inhibitory effect on the CNS which limits the output of spinal motoneurons and therefore endurance performance (11).

How do group III/IV muscle afferents limit the output from spinal motoneurons?

Decreases in the output from spinal motoneurons have been suggested to result from group III/IV muscle afferent feedback inhibiting voluntary descending drive ‘upstream’ of the motor cortex and/or a afferents-mediated depression of the net responsiveness of the corticospinal tract including motor cortical cells and spinal motoneurons (32, 41, 54, 55, 57, 58). Although the inhibition of voluntary descending drive through muscle afferents acting upstream of the motor cortex is generally accepted as the key mechanism of group III/IV-related central fatigue, the significance of the corticospinal tract responsiveness (and its susceptibility to neural feedback) in the context of central fatigue remains ambiguous. Four types of inconsistent observations fuel this controversy.

First, studies based on maximal isometric single muscle contraction and PECO suggest a dissociation between group III/IV muscle afferent feedback and alterations in the responsiveness of the corticospinal tract (27, 57). Specifically, the responsiveness of both spinal motoneurons and motor cortical output cells was shown to recover despite continuous afferent firing following exercise (via PECO) (57). Second, in direct contrast to this, other single-joint studies suggest that stimulation of group III/IV muscle afferents via PECO or hypertonic saline causes a net corticospinal depression resulting from a motor cortical inhibition combined with either facilitated (42) or inhibited (41) spinal motoneurons. Third, exercise-induced decreases in voluntary muscle activation during maximal, isometric single-joint contractions may be unrelated to alterations in corticospinal responsiveness. This was concluded based on the observation that despite continuous afferent firing following fatiguing elbow flexion (via PECO), the responsiveness of both the spine and the brain recovered while voluntary muscle activation remained depressed and only recovered after the cuff was released and afferent firing decreased (27, 57). Fourth, studies using pharmacological blockade of group III/IV muscle afferents during exhaustive whole body endurance exercise (i.e. cycling) suggest that exercise-induced decreases in the responsiveness of motor cortical output cells coincide with a restricted output from spinal motoneurons and a decrease in voluntary muscle activation (54, 55). Taken together, the actual role of exercise-induced alterations on corticospinal tract responsiveness in central fatigue, and the influence of group III/IV afferents on these changes, remain elusive. Some of the controversial observations briefly mentioned in this section might be explained by potential differences between exercise modalities (53) and/or a combination of issues discussed below.

Subtypes of Group III/IV Muscle Afferents: Critical Considerations on Anatomical and Functional Differences

Recently, two different subtypes of chemosensitive group III/IV muscle afferents characterized by anatomical and functional differences have been discovered in animals (17, 30, 34, 40, 45) and humans (50). One subtype, the so-called metabo- or ergoreceptors, was documented to only respond to innocuous levels of intramuscular metabolites (lactate, ATP, protons) associated with ‘normal’ (i.e. freely perfused and predominantly aerobic) exercise (14, 31, 39) up to strenuous intensities. In contrast, the other subtype, the so-called metabonociceptors, only respond to higher (and concurrently noxious) levels of metabolites present in muscle during ischaemic contractions or following hypertonic saline infusions – but not to non-noxious metabolite concentrations associated with normal exercise (34, 40, 50).

The specific phenotypical distinction of metaboreceptors vs metabo-nociceptors remains elusive to date. It is, however, recognized that molecular differences between the subtypes includes the differential expression of purinergic receptors (P2X2,3,4), transient receptor potential vanilloid type 1 and/or 2 (TRPV1/2), and acid-sensing ion channels 1, 2, and 3 (ASIC 1-3) (17, 30, 34, 40). Although the two different subtypes of group III/IV muscle afferents project to the same location in the superficial dorsal horn (34), it is currently unknown to what degree each subtype is anatomically linked to lamina I neurons which have direct projections to various supraspinal sites.

The recent recognition of functional and structural differences between metaboreceptors and metabo-nociceptors (17, 30, 34, 40, 45, 50) suggests that PECO or hypertonic saline infusions may no longer be considered optimal techniques for investigating the role of those group III/IV muscle afferents which are active during normal, freely perfused exercise of light to strenuous intensity (i.e. ergoreceptors) on circulation, ventilation and central fatigue. This is simply because these techniques likely evoke neural feedback which is mediated via the metabo-nociceptors which may not even be active during normal exercise/activity. Furthermore, investigations addressing the effects of cardiovascular pathologies (e.g. heart failure) in humans and animals on the sensitivity of group III vs group IV muscle afferents using PECO or other noxious stimuli might focus more on metabo-nociceptive pathways and thereby contribute to the controversy surrounding this question (44, 48). Taken together, recent critical discoveries addressing the existence of different subtypes of group III/IV muscle afferents (17, 30, 34, 40, 45, 50) caution a careful consideration of hypertonic saline and PECO studies (i.e. musculoskeletal pain) intended to address the role of group III/IV-mediated neural feedback during exercise.

Conclusion

Group III and IV muscle afferents play a significant role in the development of fatigue during exercise in humans. These sensory neurons determine autonomic responses to exercise which assure adequate muscle blood flow/O2 delivery during physical activity and are a key determinant in minimizing the rate of peripheral fatigue development and optimizing exercise performance. However, the very same muscle afferents also exert inhibitory effects on the CNS which diminishes the output from spinal motoneurons, decreases voluntary muscle activation (i.e. facilitates central fatigue), and impairs exercise performance. Despite the fact that group III/IV muscle afferents might be considered a “double-edged sword” (10), feedback from these sensory neurons assures adequate ventilatory and circulatory responses and protects the exercising human from potentially catastrophic exercise-induced homeostatic failure by a CNS-mediated restriction of muscular activities.

Acknowledgments

Funding for this work was received from the National Institutes of Health (HL-103786 and HL-116579) and the American Heart Association (AHA 14 17770016).

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Adreani CM, Hill JM, Kaufman MP. Responses of group III and IV muscle afferents to dynamic exercise. J Appl Physiol. 1997;82:1811–1817. doi: 10.1152/jappl.1997.82.6.1811. [DOI] [PubMed] [Google Scholar]
  • 2.Alam M, Smirk FH. Observations in man upon a blood pressure raising reflex arising from the voluntary muscles. J Physiol. 1937;89:372–383. doi: 10.1113/jphysiol.1937.sp003485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev. 2008;88:287–332. doi: 10.1152/physrev.00015.2007. [DOI] [PubMed] [Google Scholar]
  • 4.Amann M, Blain GM, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Group III and IV muscle afferents contribute to ventilatory and cardiovascular response to rhythmic exercise in humans. J Appl Physiol. 2010;109:966–976. doi: 10.1152/japplphysiol.00462.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Amann M, Blain GM, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Implications of group III and IV muscle afferents for high intensity endurance exercise performance in humans. J Physiol. 2011;589:5299–5309. doi: 10.1113/jphysiol.2011.213769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Amann M, Calbet JA. Convective oxygen transport and fatigue. J Appl Physiol. 2008;104:861–870. doi: 10.1152/japplphysiol.01008.2007. [DOI] [PubMed] [Google Scholar]
  • 7.Amann M, Proctor LT, Sebranek JJ, Eldridge MW, Pegelow DF, Dempsey JA. Somatosensory feedback from the limbs exerts inhibitory influences on central neural drive during whole body endurance exercise. J Appl Physiol. 2008;105:1714–1724. doi: 10.1152/japplphysiol.90456.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Amann M, Proctor LT, Sebranek JJ, Pegelow DF, Dempsey JA. Opioid-mediated muscle afferents inhibit central motor drive and limit peripheral muscle fatigue development in humans. J Physiol. 2009;587:271–283. doi: 10.1113/jphysiol.2008.163303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Amann M, Runnels S, Morgan DE, Trinity JD, Fjeldstad AS, Wray DW, Reese VR, Richardson RS. On the contribution of group III and IV muscle afferents to the circulatory response to rhythmic exercise in humans. J Physiol. 2011;589:3855–3866. doi: 10.1113/jphysiol.2011.209353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Amann M, Secher NH. Afferent feedback from fatigued locomotor muscles is an important determinant of endurance exercise performance. J Appl Physiol. 2010;108:452–454. doi: 10.1152/japplphysiol.00976.2009. [DOI] [PubMed] [Google Scholar]
  • 11.Amann M, Venturelli M, Ives SJ, McDaniel J, Layec G, Rossman MJ, Richardson RS. Peripheral fatigue limits endurance exercise via a sensory feedback-mediated reduction in spinal motoneuronal output. J Appl Physiol (1985) 2013;115:355–364. doi: 10.1152/japplphysiol.00049.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Amann M, Venturelli M, Ives SJ, Morgan DE, Gmelch B, Witman MA, Jonathan Groot H, Wray WD, Stehlik J, Richardson RS. Group III/IV muscle afferents impair limb blood in patients with chronic heart failure. Int J Cardiol. 2014;174:368–375. doi: 10.1016/j.ijcard.2014.04.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Asmussen E, Nielsen M, Wieth-Pedersen G. Cortical or reflex control of respiration during muscular work. Acta Physiol Scand. 1943;6:168–175. [Google Scholar]
  • 14.Bangsbo J, Johansen L, Graham T, Saltin B. Lactate and H+ effluxes from human skeletal muscles during intense, dynamic exercise. J Physiol. 1993;462:115–133. doi: 10.1113/jphysiol.1993.sp019546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Barclay JK. A delivery-independent blood flow effect on skeletal muscle fatigue. J Appl Physiol. 1986;61:1084–1090. doi: 10.1152/jappl.1986.61.3.1084. [DOI] [PubMed] [Google Scholar]
  • 16.Bigland-Ritchie BR, Dawson NJ, Johansson RS, Lippold OC. Reflex origin for the slowing of motoneurone firing rates in fatigue of human voluntary contractions. J Physiol. 1986;379:451–459. doi: 10.1113/jphysiol.1986.sp016263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Birdsong WT, Fierro L, Williams FG, Spelta V, Naves LA, Knowles M, Marsh-Haffner J, Adelman JP, Almers W, Elde RP, McCleskey EW. Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels. Neuron. 2010;68:739–749. doi: 10.1016/j.neuron.2010.09.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Brooks JC, Zambreanu L, Godinez A, Craig AD, Tracey I. Somatotopic organisation of the human insula to painful heat studied with high resolution functional imaging. Neuroimage. 2005;27:201–209. doi: 10.1016/j.neuroimage.2005.03.041. [DOI] [PubMed] [Google Scholar]
  • 19.Coote JH, Hilton SM, Perez-Gonzalez JF. The reflex nature of the pressor response to muscular exercise. J Physiol. 1971;215:789–804. doi: 10.1113/jphysiol.1971.sp009498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Craig AD. Distribution of brainstem projections from spinal lamina I neurons in the cat and the monkey. J Comp Neurol. 1995;361:225–248. doi: 10.1002/cne.903610204. [DOI] [PubMed] [Google Scholar]
  • 21.Craig AD. Pain mechanisms: labeled lines versus convergence in central processing. Annu Rev Neurosci. 2003;26:1–30. doi: 10.1146/annurev.neuro.26.041002.131022. [DOI] [PubMed] [Google Scholar]
  • 22.Dempsey JA, Blain GM, Amann M. Are type III - IV muscle afferents required for a normal steady state exercise hyperpnea In humans? J Physiol. 2014;592:463–474. doi: 10.1113/jphysiol.2013.261925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Fisher JP, Seifert T, Hartwich D, Young CN, Secher NH, Fadel PJ. Autonomic control of heart rate by metabolically sensitive skeletal muscle afferents in humans. J Physiol. 2010;588:1117–1127. doi: 10.1113/jphysiol.2009.185470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fulco CS, Lewis SF, Frykman PN, Boushel R, Smith S, Harman EA, Cymerman A, Pandolf KB. Muscle fatigue and exhaustion during dynamic leg exercise in normoxia and hypobaric hypoxia. J Appl Physiol. 1996;81:1891–1900. doi: 10.1152/jappl.1996.81.5.1891. [DOI] [PubMed] [Google Scholar]
  • 25.Gagnon P, Bussieres JS, Ribeiro F, Gagnon SL, Saey D, Gagne N, Provencher S, Maltais F. Influences of spinal anesthesia on exercise tolerance in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186:606–615. doi: 10.1164/rccm.201203-0404OC. [DOI] [PubMed] [Google Scholar]
  • 26.Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev. 2001;81:1725–1789. doi: 10.1152/physrev.2001.81.4.1725. [DOI] [PubMed] [Google Scholar]
  • 27.Gandevia SC, Allen GM, Butler JE, Taylor JL. Supraspinal factors in human muscle fatigue: evidence for suboptimal output from the motor cortex. J Physiol. 1996;490(Pt 2):529–536. doi: 10.1113/jphysiol.1996.sp021164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Gandevia SC, Macefield G, Burke D, McKenzie DK. Voluntary activation of human motor axons in the absence of muscle afferent feedback. The control of the deafferented hand. Brain. 1990;490(Pt 2):529–536. doi: 10.1093/brain/113.5.1563. [DOI] [PubMed] [Google Scholar]
  • 29.Garry MG. Abnormalities of the exercise pressor reflex in heart failure. Exerc Sport Sci Rev. 2011;39:167–176. doi: 10.1097/JES.0b013e31822a5621. [DOI] [PubMed] [Google Scholar]
  • 30.Gautam M, Benson CJ. Acid-sensing ion channels (ASICs) in mouse skeletal muscle afferents are heteromers composed of ASIC1a, ASIC2, and ASIC3 subunits. FASEB J. 2013;27:793–802. doi: 10.1096/fj.12-220400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Hellsten Y, Maclean D, Radegran G, Saltin B, Bangsbo J. Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation. 1998;98:6–8. doi: 10.1161/01.cir.98.1.6. [DOI] [PubMed] [Google Scholar]
  • 32.Hilty L, Lutz K, Maurer K, Rodenkirch T, Spengler CM, Boutellier U, Jancke L, Amann M. Spinal opioid receptor-sensitive muscle afferents contribute to the fatigue-induced increase in intracortical inhibition in healthy humans. Exp Physiol. 2011;96:505–517. doi: 10.1113/expphysiol.2010.056226. [DOI] [PubMed] [Google Scholar]
  • 33.Hollander AP, Bouman LN. Cardiac acceleration in man elicited by a muscle-heart reflex. J Appl Physiol. 1975;38:272–278. doi: 10.1152/jappl.1975.38.2.272. [DOI] [PubMed] [Google Scholar]
  • 34.Jankowski MP, Rau KK, Ekmann KM, Anderson CE, Koerber HR. Comprehensive phenotyping of group III and IV muscle afferents in mouse. J Neurophysiol. 2013;109:2374–2381. doi: 10.1152/jn.01067.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kao FF. An experimental study of the pathway involved in exercise hyperpnea employing cross-circulation technique. In. In: Cunningham DJC, Lloyd BB, editors. The regulation of human respiration. Oxford: Blackwell; 1963. pp. 461–502. [Google Scholar]
  • 36.Katayama K, Amann M, Pegelow DF, Jacques AJ, Dempsey JA. Effect of arterial oxygenation on quadriceps fatigability during isolated muscle exercise. Am J Physiol Regul Integr Comp Physiol. 2007;292:R1279–1286. doi: 10.1152/ajpregu.00554.2006. [DOI] [PubMed] [Google Scholar]
  • 37.Kaufman MP, Longhurst JC, Rybicki KJ, Wallach JH, Mitchell JH. Effects of static muscular contraction on impulse activity of groups III and IV afferents in cats. J Appl Physiol. 1983;55:105–112. doi: 10.1152/jappl.1983.55.1.105. [DOI] [PubMed] [Google Scholar]
  • 38.Kim JK, Sala-Mercado JA, Rodriguez J, Scislo TJ, O’Leary DS. Arterial baroreflex alters strength and mechanisms of muscle metaboreflex during dynamic exercise. Am J Physiol Heart Circ Physiol. 2005;288:H1374–1380. doi: 10.1152/ajpheart.01040.2004. [DOI] [PubMed] [Google Scholar]
  • 39.Li J, King NC, Sinoway LI. ATP concentrations and muscle tension increase linearly with muscle contraction. J Appl Physiol. 2003;95:577–583. doi: 10.1152/japplphysiol.00185.2003. [DOI] [PubMed] [Google Scholar]
  • 40.Light AR, Hughen RW, Zhang J, Rainier J, Liu Z, Lee J. Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate mediated by ASIC, P2X, and TRPV1. J Neurophysiol. 2008;100:1184–1201. doi: 10.1152/jn.01344.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Martin PG, Smith JL, Butler JE, Gandevia SC, Taylor JL. Fatigue-sensitive afferents inhibit extensor but not flexor motoneurons in humans. J Neurosci. 2006;26:4796–4802. doi: 10.1523/JNEUROSCI.5487-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Martin PG, Weerakkody N, Gandevia SC, Taylor JL. Group III and IV muscle afferents differentially affect the motor cortex and motoneurones in humans. J Physiol. 2008;586:1277–1289. doi: 10.1113/jphysiol.2007.140426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.McCloskey DI, Mitchell JH. Reflex cardiovascular and respiratory responses originating in exercising muscle. J Physiol. 1972;224:173–186. doi: 10.1113/jphysiol.1972.sp009887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Middlekauff HR, Sinoway LI. Increased mechanoreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol. 2007;102:492–494. doi: 10.1152/japplphysiol.00994.2006. discussion 496. [DOI] [PubMed] [Google Scholar]
  • 45.Naves LA, McCleskey EW. An acid-sensing ion channel that detects ischemic pain. Braz J Med Biol Res. 2005;38:1561–1569. doi: 10.1590/s0100-879x2005001100001. [DOI] [PubMed] [Google Scholar]
  • 46.Notarius CF, Atchison DJ, Floras JS. Impact of heart failure and exercise capacity on sympathetic response to handgrip exercise. Am J Physiol Heart Circ Physiol. 2001;280:H969–976. doi: 10.1152/ajpheart.2001.280.3.H969. [DOI] [PubMed] [Google Scholar]
  • 47.Olson TP, Joyner MJ, Eisenach JH, Curry TB, Johnson BD. Influence of locomotor muscle afferent inhibition on the ventilatory response to exercise in heart failure. Exp Physiol. 2014;99:414–426. doi: 10.1113/expphysiol.2013.075937. [DOI] [PubMed] [Google Scholar]
  • 48.Piepoli MF, Coats AJ. Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. J Appl Physiol. 2007;102:494–496. doi: 10.1152/japplphysiol.00994a.2006. discussion 496-497. [DOI] [PubMed] [Google Scholar]
  • 49.Piepoli MF, Dimopoulos K, Concu A, Crisafulli A. Cardiovascular and ventilatory control during exercise in chronic heart failure: role of muscle reflexes. Int J Cardiol. 2008;130:3–10. doi: 10.1016/j.ijcard.2008.02.030. [DOI] [PubMed] [Google Scholar]
  • 50.Pollak KA, Swenson JD, Vanhaitsma TA, Hughen RW, Jo D, Light KC, Schweinhardt P, Amann M, Light AR. Exogenously applied muscle metabolites synergistically evoke sensations of muscle fatigue and pain in human subjects. Exp Physiol. 2014;99(2):368–380. doi: 10.1113/expphysiol.2013.075812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Secher NH, Amann M. Human investigations into the exercise pressor reflex. Exp Physiol. 2012;97:59–69. doi: 10.1113/expphysiol.2011.057679. [DOI] [PubMed] [Google Scholar]
  • 52.Sheriff DD, O’Leary DS, Scher AM, Rowell LB. Baroreflex attenuates pressor response to graded muscle ischemia in exercising dogs. Am J Physiol. 1990;258:H305–310. doi: 10.1152/ajpheart.1990.258.2.H305. [DOI] [PubMed] [Google Scholar]
  • 53.Sidhu SK, Cresswell AG, Carroll TJ. Corticospinal responses to sustained locomotor exercises: moving beyond single-joint studies of central fatigue. Sports Med. 2013;43:437–449. doi: 10.1007/s40279-013-0020-6. [DOI] [PubMed] [Google Scholar]
  • 54.Sidhu SK, Weavil JC, Mangum TS, Morgan DE, Jessop JE, Richardson RS, Amann M. Group III/IV locomotor muscle afferents decrease responsiveness of motor cortical cells and facilitates supraspinal fatigue. J Physiol. 2014 [Google Scholar]
  • 55.Sidhu SK, Weavil JC, Venturelli M, Garten RS, Rossman MJ, Richardson RS, Gmelch BS, Morgan DE, Amann M. Spinal μ-opioid receptor sensitive lower limb muscle afferents determine corticospinal responsiveness and exacerbate central fatigue in upper limb muscle. J Physiol. 2014 doi: 10.1113/jphysiol.2014.275438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Taylor JL, Butler JE, Allen GM, Gandevia SC. Changes in motor cortical excitability during human muscle fatigue. J Physiol. 1996;490(Pt 2):519–528. doi: 10.1113/jphysiol.1996.sp021163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Taylor JL, Petersen N, Butler JE, Gandevia SC. Ischaemia after exercise does not reduce responses of human motoneurones to cortical or corticospinal tract stimulation. J Physiol. 2000;525(Pt 3):793–801. doi: 10.1111/j.1469-7793.2000.00793.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Taylor JL, Todd G, Gandevia SC. Evidence for a supraspinal contribution to human muscle fatigue. Clin Exp Pharmacol Physiol. 2006;33:400–405. doi: 10.1111/j.1440-1681.2006.04363.x. [DOI] [PubMed] [Google Scholar]
  • 59.Tibes U. Reflex inputs to the cardiovascular and respiratory centers from dynamically working canine muscles. Some evidence for involvement of group III or IV nerve fibers. Circ Res. 1977;41:332–341. doi: 10.1161/01.res.41.3.332. [DOI] [PubMed] [Google Scholar]
  • 60.Waldrop TG, Eldridge FL, Iwamoto GA, Mitchell JH. Central neural control of respiration and circulation during exercise. In: Rowell LB, Shepherd JT, editors. Handbook of Physiology Section 12: Exercise: Regulation and Integration of Multiple Systems. New York: Oxford University Press; 1996. pp. 333–380. [Google Scholar]
  • 61.Waldrop TG, Mitchell JH. Effects of barodenervation on cardiovascular responses to static muscular contraction. Am J Physiol. 1985;249:H710–714. doi: 10.1152/ajpheart.1985.249.4.H710. [DOI] [PubMed] [Google Scholar]
  • 62.Wilson LB, Andrew D, Craig AD. Activation of spinobulbar lamina I neurons by static muscle contraction. J Neurophysiol. 2002;87:1641–1645. doi: 10.1152/jn.00609.2001. [DOI] [PubMed] [Google Scholar]
  • 63.Wilson LB, Hand GA. The pressor reflex evoked by static contraction: neurochemistry at the site of the first synapse. Brain Res Brain Res Rev. 1997;23:196–209. doi: 10.1016/s0165-0173(96)00019-7. [DOI] [PubMed] [Google Scholar]

RESOURCES